Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael E Matheny

Showing results (161-170 of 251) with videos related to

Pageof 26
Sort By:
BMC Nephrology|November 25, 2016
High prevalence of non-steroidal anti-inflammatory drug use among acute kidney injury survivors in the southern community cohort studyLoren Lipworth, Khaled Abdel-Kader, Jennifer Morse, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 21, 2019
Timing of Recovery From Moderate to Severe AKI and the Risk for Future Loss of Kidney FunctionEdward D Siew, Khaled Abdel-Kader, Amy M Perkins, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 30, 2013
Adverse drug events during AKI and its recoveryZachary L Cox, Allison B McCoy, Michael E Matheny, et al.
Journal of Biomedical Informatics|June 26, 2021
Adaptation of an NLP system to a new healthcare environment to identify social determinants of healthRuth M Reeves, Lee Christensen, Jeremiah R Brown, et al.
BMJ Surgery, Interventions, & Health Technologies|January 20, 2022
Impact of early surveillance on safety signal identification in the CathPCI DELTA studyArjun Majithia, Michael E Matheny, Sourbha S Dani, et al.
Journal of the American Heart Association|December 15, 2015
Acute Kidney Injury Risk Prediction in Patients Undergoing Coronary Angiography in a National Veterans Health Administration Cohort With External ValidationJeremiah R Brown, Todd A MacKenzie, Thomas M Maddox, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 23, 2017
Acute Kidney Injury and Risk of Incident Heart Failure Among US VeteransNisha Bansal, Michael E Matheny, Robert A Greevy, et al.
Cardiovascular Drugs and Therapy|February 1, 2021
Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease-Perspective from the Veterans Affair Healthcare SystemXiaoming Jia, Michelle T Lee, David J Ramsey, et al.
Kidney International|September 11, 2020
Renin-angiotensin aldosterone inhibitor use at hospital discharge among patients with moderate to severe acute kidney injury and its association with recurrent acute kidney injury and mortalityEdward D Siew, Sharidan K Parr, Khaled Abdel-Kader, et al.
Drug Safety|April 13, 2026
Health Information Exchanges (HIEs) as Novel Sources for Population-Based Post Marketing Surveillance of Medical Products: A Pilot Study from the FDA Sentinel Innovation CenterAnjum Khurshid, David Kendrick, Haritha S Pillai, et al.
Pageof 26

Showing results (161-170 of 251) with videos related to

Sort By:
Pageof 26
BMC Nephrology|November 25, 2016
High prevalence of non-steroidal anti-inflammatory drug use among acute kidney injury survivors in the southern community cohort studyLoren Lipworth, Khaled Abdel-Kader, Jennifer Morse, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 21, 2019
Timing of Recovery From Moderate to Severe AKI and the Risk for Future Loss of Kidney FunctionEdward D Siew, Khaled Abdel-Kader, Amy M Perkins, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 30, 2013
Adverse drug events during AKI and its recoveryZachary L Cox, Allison B McCoy, Michael E Matheny, et al.
Journal of Biomedical Informatics|June 26, 2021
Adaptation of an NLP system to a new healthcare environment to identify social determinants of healthRuth M Reeves, Lee Christensen, Jeremiah R Brown, et al.
BMJ Surgery, Interventions, & Health Technologies|January 20, 2022
Impact of early surveillance on safety signal identification in the CathPCI DELTA studyArjun Majithia, Michael E Matheny, Sourbha S Dani, et al.
Journal of the American Heart Association|December 15, 2015
Acute Kidney Injury Risk Prediction in Patients Undergoing Coronary Angiography in a National Veterans Health Administration Cohort With External ValidationJeremiah R Brown, Todd A MacKenzie, Thomas M Maddox, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 23, 2017
Acute Kidney Injury and Risk of Incident Heart Failure Among US VeteransNisha Bansal, Michael E Matheny, Robert A Greevy, et al.
Cardiovascular Drugs and Therapy|February 1, 2021
Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease-Perspective from the Veterans Affair Healthcare SystemXiaoming Jia, Michelle T Lee, David J Ramsey, et al.
Kidney International|September 11, 2020
Renin-angiotensin aldosterone inhibitor use at hospital discharge among patients with moderate to severe acute kidney injury and its association with recurrent acute kidney injury and mortalityEdward D Siew, Sharidan K Parr, Khaled Abdel-Kader, et al.
Drug Safety|April 13, 2026
Health Information Exchanges (HIEs) as Novel Sources for Population-Based Post Marketing Surveillance of Medical Products: A Pilot Study from the FDA Sentinel Innovation CenterAnjum Khurshid, David Kendrick, Haritha S Pillai, et al.
Pageof 26